Selecta Biosciences, Inc.
Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity
Last updated:
Abstract:
Disclosed are methods and related compositions for concomitantly, locally administering immunosuppressants and doses of therapeutic macromolecules for reducing Type I and Type IV hypersensitivity.
Status:
Grant
Type:
Utility
Filling date:
11 Jun 2019
Issue date:
12 Apr 2022